News | Artificial Intelligence | November 13, 2018

Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018

Deep learning algorithms designed for faster scans and reduced radiation dose

Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018

November 13, 2018 — At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical will showcase SubtlePET, its artificial intelligence (AI)-powered technology. SubtlePET allows hospitals and imaging centers to deliver a faster and safer patient scanning experience, while enhancing exam throughput and provider profitability. The software is currently under U.S. Food and Drug Administration (FDA) 510k review and in pilot use in multiple university hospitals and imaging centers in the U.S. and abroad.

SubtlePET leverages AI to allow hospitals and imaging centers to accelerate positron emission tomography (PET) scan times four-fold or reduce PET radiation dose by up to 75 percent, according to the company.

A second product pending FDA submission is SubtleMRI, which allows imaging centers to significantly accelerate magnetic resonance imaging (MRI) scans. Subtle Medical’s focus on image acquisition and workflow differentiates it from most AI imaging companies, which are focusing on post-processing and computer-aided diagnosis.

Subtle Medical technology utilizes deep learning algorithms that integrate seamlessly with any original equipment manufacturer (OEM) PET and MRI scanners to enhance images during acquisition without any interruption or alteration in the imaging specialists’ workflow.  The result is shorter scan duration or less exposure to radiation, which is particularly beneficial for children and those undergoing repeat PET exams.

In March 2018, Subtle Medical received the NVIDIA Inception Award Top Healthcare+AI Startup Globally from among over 3,000 AI contenders. The company was also selected as the first AI+healthcare startup for Bessemer Venture Partner’s Deep Health Seed Program.

Subtle Medical’s core technology was developed at Stanford University.  The company has licensed multiple patented technologies invented by the founders at Stanford as well as medical imaging datasets acquired during clinical research at Stanford radiology labs.

At RSNA 2018, Subtle Medical’s co-founders will be participating in research and industry presentations along with other academic collaborators from Stanford. Presentations include:

Lunch and Learn: Thinking Faster, Safer, & Smarter: How You Can Use AI to improve MR and PET Imaging Efficiency, Patient Satisfaction, and Safety

Greg Zaharchuk, M.D., Ph.D. |Chris Hess, M.D., Ph.D. | Paul Chang, MS, M.D. | Michael Brant-Zawadzki, M.D., FACR

Wednesday 12:30-1:30 PM | LL33  

 

Machine Learning Theater: AI Improves Imaging Workflow for MR and PET Exams: Faster, Safer, and Smarter

Greg Zaharchuk, M.D., Ph.D. |Enhao Gong, Ph.D.

Monday 12:00-12:20 PM | ML23

 

Evaluation of Deep-Learning-Based Technology for Reducing Gadolinium Dosage in Contrast-Enhanced MRI Exams

Enhao Gong, Ph.D. | Jonathan Tamir, BSC | John Pauly | Max Wintermark, M.D. | Greg Zaharchuk, M.D., Ph.D.

Physics (MR: New Techniques, Systems, Evaluation)

Monday 10:30-12:00 PM | SSC12 | Presentation 9 of 9

 

Does 18F-FDG Dose Reduction for PET/MRI Affect Treatment Response Assessment of Lymphomas and Sarcomas?

Ketan Yerneni |Anne Muehe, M.D. | Praveen Gulaka, Ph.D. | K. Elizabeth Hawk, M.D., Ph.D. | Ashok Joseph Theruvath, M.D. | Heike Daldrup-Link, M.D.

Monday 12:45-1:15 PM | PD218-SD-MOB4

 

Stroke Outcome Prediction from Meta Information Available at Patient Admission

Yuan Xie | Bin Jiang | Enhao Gong, Ph.D. | Ying N. Li | Guangming Zhu | Bo Zhou | Patrik Michel | Max Wintermark, M.D. | Greg Zaharchuk, M.D., Ph.D.

Neuroradiology Series: Stroke

Wednesday 8:30-12:00 PM | RC505 | Presentation 10 of 12

 

Deep Learning Segmentation for Detection of Brain Metastases in the Small Data Regime

Daniel L. Rubin, M.D., MS | Greg Zaharchuk, M.D., Ph.D. | Michael Iv, M.D. | Rhea Singh

Neuroradiology (Dots and Dashes: Image Analysis in Neuroradiology)

Thursday 10:30-12:00 PM | SSQ15 | Presentation 8 of 9

For more information: www.subtlemedical.com

 

Related Content

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

News | Magnetic Resonance Imaging (MRI) | July 02, 2020
July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commerci
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

News | Magnetic Resonance Imaging (MRI) | July 01, 2020
July 1, 2020 — Researchers using magnetic...
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Sponsored Content | Videos | PACS | June 29, 2020
Kevin Borden, Vice President of Product, Healthcare IT for Konica Minolta, talks about Improving Access and Aiding Wo